<DOC>
	<DOCNO>NCT00919347</DOCNO>
	<brief_summary>The purpose study measure prevalence severity cardiac autonomic neuropathy ( CAN ) , diabetic autonomic neuropathy ( DAN ) non-diabetics term advanced nervous system ( ANS ) dysfunction , autonomic dysfunction well overall sympathovagal balance ( SB ) CEFH population diabetic patient versus non-diabetic patient undergo elective vitreoretinal surgery .</brief_summary>
	<brief_title>The Relative Prevalence Severity Autonomic Nervous System Dysfunction</brief_title>
	<detailed_description>The purpose study measure prevalence severity cardiac autonomic neuropathy ( CAN ) , diabetic autonomic neuropathy ( DAN ) non-diabetics term advanced nervous system ( ANS ) dysfunction , autonomic dysfunction well overall sympathovagal balance ( SB ) CEFH population diabetic patient versus non-diabetic patient undergo elective vitreoretinal surgery .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Autonomic Nervous System Diseases</mesh_term>
	<mesh_term>Primary Dysautonomias</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Type I Type II Diabetic patient 19 old schedule elective surgery improve vision impair diabetic retinopathy Patients scheduled time period without diabetes retinal surgery serve age gender match reference group undergo noninvasive ANS test day surgery Inability stand baseline , deep breathing Valsalva portion ( AD ) test describe section 8.1 Patients syncope stand portion AD test Inability cooperate deep breathing Valsalva Tracheoscopy otherwise able perform Valsalva Not desire participate inform consent Known history idiopathic dysautonomia Pulmonary difficulty associate hyperventilation , include acute URI Pacemaker dependent Persistently high intraocular pressure despite treatment Atrial fibrillation Ventricular arrhythmia great 10 beat per minute Taking MAO inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Cardiovascular Autonomic Neuropathy</keyword>
	<keyword>Diabetic Autonomic Neuropathy</keyword>
	<keyword>Autonomic Dysfunction</keyword>
</DOC>